+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.526 HKD | -0.182 | -3.866% | 300.11M | 1.38B | 4.455 (+1.603%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 2.064 HKD | +0.080 | +4.032% | 515.55M | 1.05B | 2.112 (-2.263%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.788 HKD | +0.054 | +1.975% | 97.51M | 270.37M | 2.859 (-2.477%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 4.308 HKD | -0.098 | -2.224% | 53.60M | 231.90M | 4.224 (+1.991%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.200 HKD | +0.070 | +0.409% | 3.42M | 59.34M | 18.076 (-4.845%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 5.955 HKD | +0.065 | +1.104% | 9.02M | 53.29M | 6.151 (-3.185%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 18.550 HKD | -0.240 | -1.277% | 704.70K | 13.21M | 18.000 (+3.057%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 2.778 HKD | -0.064 | -2.252% | 3.17M | 8.90M | 2.733 (+1.635%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 74.800 HKD | -0.400 | -0.532% | 57.41K | 4.26M | 79.342 (-5.724%) HKD as at 2025/04/22 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 4.198 HKD | +0.042 | +1.011% | 963.10K | 4.04M | 4.250 (-1.212%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 0.906 HKD | +0.010 | +1.116% | 4.09M | 3.68M | 0.937 (-3.257%) HKD as at 2025/04/22 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | S&P Bitcoin Futures Index | 4.842 HKD | +0.112 | +2.368% | 679.50K | 3.25M | 4.859 (-0.340%) HKD as at 2025/04/22 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng China Enterprises | 2.070 HKD | +0.040 | +1.970% | 1.39M | 2.88M | 2.113 (-2.054%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | CSI 300 | 3.354 HKD | -0.006 | -0.179% | 696.50K | 2.34M | 3.367 (-0.389%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 2.936 HKD | -0.044 | -1.477% | 499.00K | 1.48M | 2.985 (-1.642%) HKD as at 2025/04/23 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | NASDAQ-100 Index | 24.460 HKD | -0.220 | -0.891% | 12.00K | 295.53K | 23.684 (+3.277%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Nikkei Stock Average Index | 62.900 HKD | -0.220 | -0.349% | 3.97K | 251.04K | 61.256 (+2.683%) HKD as at 2025/04/22 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | FTSE Taiwan RIC Capped Index | 9.375 HKD | -0.145 | -1.523% | 7.30K | 69.34K | 1.140 (+5.992%) USD as at 2025/04/22 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | FTSE Taiwan RIC Capped Index | 4.828 HKD | +0.048 | +1.004% | 5.00K | 23.90K | 0.637 (-2.342%) USD as at 2025/04/22 | | |